import{_ as e,o as i,c as t,O as r}from"./chunks/framework.9482e208.js";const f=JSON.parse('{"title":"§ 54.1-3300 Definitions.","description":"","frontmatter":{},"headers":[],"relativePath":"vacode/54.1-3300.md","filePath":"vacode/54.1-3300.md"}'),a={name:"vacode/54.1-3300.md"},n=r('<h1 id="§-54-1-3300-definitions" tabindex="-1">§ 54.1-3300 Definitions. <a class="header-anchor" href="#§-54-1-3300-definitions" aria-label="Permalink to &quot;§ 54.1-3300 Definitions.&quot;">​</a></h1><p>As used in this chapter, unless the context requires a different meaning:</p><p>&quot;Board&quot; means the Board of Pharmacy.</p><p>&quot;Collaborative agreement&quot; means a voluntary, written, or electronic arrangement between one pharmacist and his designated alternate pharmacists involved directly in patient care at a single physical location where patients receive services and (i) any person licensed to practice medicine, osteopathy, or podiatry together with any person licensed, registered, or certified by a health regulatory board of the Department of Health Professions who provides health care services to patients of such person licensed to practice medicine, osteopathy, or podiatry; (ii) a physician&#39;s office as defined in § <a href="/vacode/32.1-276.3/">32.1-276.3</a>, provided that such collaborative agreement is signed by each physician participating in the collaborative agreement; (iii) any licensed physician assistant working under the supervision of a person licensed to practice medicine, osteopathy, or podiatry; or (iv) any licensed nurse practitioner working in accordance with the provisions of § <a href="/vacode/54.1-2957/">54.1-2957</a>, involved directly in patient care which authorizes cooperative procedures with respect to patients of such practitioners. Collaborative procedures shall be related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations, for the purpose of improving patient outcomes. A collaborative agreement is not required for the management of patients of an inpatient facility.</p><p>&quot;Dispense&quot; means to deliver a drug to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing and administering, packaging, labeling, or compounding necessary to prepare the substance for delivery.</p><p>&quot;Pharmacist&quot; means a person holding a license issued by the Board to practice pharmacy.</p><p>&quot;Pharmacy&quot; means every establishment or institution in which drugs, medicines, or medicinal chemicals are dispensed or offered for sale, or a sign is displayed bearing the word or words &quot;pharmacist,&quot; &quot;pharmacy,&quot; &quot;apothecary,&quot; &quot;drugstore,&quot; &quot;druggist,&quot; &quot;drugs,&quot; &quot;medicine store,&quot; &quot;drug sundries,&quot; &quot;prescriptions filled,&quot; or any similar words intended to indicate that the practice of pharmacy is being conducted.</p><p>&quot;Pharmacy intern&quot; means a student currently enrolled in or a graduate of an approved school of pharmacy who is registered with the Board for the purpose of gaining the practical experience required to apply for licensure as a pharmacist.</p><p>&quot;Pharmacy technician&quot; means a person registered with the Board to assist a pharmacist under the pharmacist&#39;s supervision.</p><p>&quot;Pharmacy technician trainee&quot; means a person registered with the Board for the purpose of performing duties restricted to a pharmacy technician as part of a pharmacy technician training program in accordance with the provisions of subsection G of § <a href="/vacode/54.1-3321/">54.1-3321</a>.</p><p>&quot;Practice of pharmacy&quot; means the personal health service that is concerned with the art and science of selecting, procuring, recommending, administering, preparing, compounding, packaging, and dispensing of drugs, medicines, and devices used in the diagnosis, treatment, or prevention of disease, whether compounded or dispensed on a prescription or otherwise legally dispensed or distributed, and shall include (i) the proper and safe storage and distribution of drugs; (ii) the maintenance of proper records; (iii) the responsibility of providing information concerning drugs and medicines and their therapeutic values and uses in the treatment and prevention of disease; (iv) the management of patient care under the terms of a collaborative agreement as defined in this section; and (v) the initiating of treatment with or dispensing or administering of certain drugs, devices, or controlled paraphernalia in accordance with the provisions of § <a href="/vacode/54.1-3303.1/">54.1-3303.1</a>.</p><p>&quot;Supervision&quot; means the direction and control by a pharmacist of the activities of a pharmacy intern or a pharmacy technician whereby the supervising pharmacist is physically present in the pharmacy or in the facility in which the pharmacy is located when the intern or technician is performing duties restricted to a pharmacy intern or technician, respectively, and is available for immediate oral communication.</p><p>Other terms used in the context of this chapter shall be defined as provided in Chapter 34 (§ <a href="/vacode/54.1-3400/">54.1-3400</a> et seq.) unless the context requires a different meaning.</p><p>Code 1950, §§ 54-399, 54-487; 1952, c. 451; 1958, c. 551, § 54-524.2; 1966, c. 193; 1968, c. 582; 1970, c. 650; 1971, Ex. Sess., c. 94; 1972, c. 798; 1975, c. 425; 1976, c. 14; 1977, c. 193; 1978, c. 833; 1979, c. 435; 1980, c. 150; 1988, c. 765; 1999, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?991+ful+CHAP0895" target="_blank" rel="noreferrer">895</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?991+ful+CHAP1011" target="_blank" rel="noreferrer">1011</a>; 2001, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?011+ful+CHAP0317" target="_blank" rel="noreferrer">317</a>; 2002, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?021+ful+CHAP0411" target="_blank" rel="noreferrer">411</a>; 2013, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?131+ful+CHAP0192" target="_blank" rel="noreferrer">192</a>; 2018, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?181+ful+CHAP0776" target="_blank" rel="noreferrer">776</a>; 2020, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0102" target="_blank" rel="noreferrer">102</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0237" target="_blank" rel="noreferrer">237</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0731" target="_blank" rel="noreferrer">731</a>; 2021, Sp. Sess. I, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?212+ful+CHAP0214" target="_blank" rel="noreferrer">214</a>.</p>',14),o=[n];function s(c,p,d,h,l,u){return i(),t("div",null,o)}const m=e(a,[["render",s]]);export{f as __pageData,m as default};
